Results 81 to 90 of about 1,113,934 (309)

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

Translating whole‐genome doubling into precision medicine in cancer

open access: yesMolecular Oncology, EarlyView.
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Smouse-et-al_JHered_mixed-assay-genotype-data_DATADRYAD

open access: yes, 2013
Microsatellite genotypes and allele frequencies for datasets described in the paper. Included are genotypes for adult trees; pericarp- and leaf-derived genotypes for seedlings from open patches; and pericarp- and leaf-derived genotypes for seedlings from
Douglas G. Scofield (3311949)   +3 more
core   +1 more source

Genotype-by-temperature interactions for life span and its micro-environmental variance in the DGRP.

open access: yes, 2020
Genotype-by-temperature interactions for life span and its micro-environmental variance in the DGRP.
W. Elizabeth Jones (5771492)   +6 more
core   +1 more source

Genotype-by-environment interaction for wheat falling number performance due to late maturity α-amylase

open access: yes, 2023
Data generated in the study 'Genotype-by-environment interaction for wheat falling number performance due to late maturity α-amylase'.
William Fairlie (4990463)
core   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Genotype-phenotype correlations in patients from Russia with phenylketonuria (N = 1243).

open access: yes, 2019
The genotype groups are marked with different shades of grey. Phenylketonuria was classified as stated in the Materials and Methods.
Polina Gundorova (5580134)   +4 more
core   +1 more source

Phenotypic plasticity in trait performance of common dairy goat breeds under diverse environments: a systematic review

open access: yesFrontiers in Animal Science
IntroductionDairy goat genotypes thrive across a range of ecological systems, making phenotypic plasticity highly relevant under constant environmental fluctuations. Maintaining production efficiency has become a priority for sustainable farming.
Puleng Kgabo Mashamaite, Obert Tada
doaj   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy